Clin Endosc.  2012 Jun;45(2):109-110. 10.5946/ce.2012.45.2.109.

Benign Colonic 18F-FDG Uptake on Whole-Body FDG-PET Scan

• Jang BI

• KMID: 2048843
• DOI: http://doi.org/10.5946/ce.2012.45.2.109

Abstract

No abstract available.

MeSH Terms

Colon
Fluorodeoxyglucose F18
Fluorodeoxyglucose F18

Reference

1. Choi YY. Clinical Application of F-18 FDG PET/PET-CT in gastrointestinal tumors. Hanyang Med Rev. 2007; 27:28–36.

2. Israel O, Yefremov N, Bar-Shalom R, et al. PET/CT detection of unexpected gastrointestinal foci of 18F-FDG uptake: incidence, localization patterns, and clinical significance. J Nucl Med. 2005; 46:758–762. PMID: 15872347.

3. Gallagher BM, Fowler JS, Gutterson NI, MacGregor RR, Wan CN, Wolf AP. Metabolic trapping as a principle of oradiopharmaceutical design: some factors resposible for the biodistribution of [18F] 2-deoxy-2-fluoro-D-glucose. J Nucl Med. 1978; 19:1154–1161. PMID: 214528.

4. Bar-Shalom R, Valdivia AY, Blaufox MD. PET imaging in oncology. Semin Nucl Med. 2000; 30:150–185. PMID: 10928381.

5. Rigo P, Paulus P, Kaschten BJ, et al. Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose. Eur J Nucl Med. 1996; 23:1641–1674. PMID: 8929320.

6. Yasuda S, Fujii H, Nakahara T, et al. 18F-FDG PET detection of colonic adenomas. J Nucl Med. 2001; 42:989–992. PMID: 11438616.

7. Shin SJ, Choi JW, Lee SK, Choi CH, Kim TI, Kim WH. A case of multiple colonic adenomas which were found incidentally in FDG-PET. Korean J Med. 2004; 66:639–643.

8. Patrikeos AP, Mackay JR, Hicks RJ. Detection of synchronous adenocarcinomas and multiple dysplastic polyps with F-18 FDG positron emission tomography in a case of nonfamilial polyposis. Clin Nucl Med. 2003; 28:487–488. PMID: 12917531.

9. Okuno T, Fu KI, Sano Y, et al. Early colon cancers detected by FDG-pet: a report of two cases with immunohistochemical investigation. Hepatogastroenterology. 2004; 51:1323–1325. PMID: 15362743.

10. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin. 2009; 59:225–249. PMID: 19474385.

11. Kang MK, Hong SP, Lee JE, et al. The usefulness of F18-FDG PET/CT in detection of colonic neoplasm. Intest Res. 2010; 8:18–23.

12. Cook GJ, Fogelman I, Maisey MN. Normal physiological and benign pathological variants of 18-fluoro-2-deoxyglucose positron-emission tomography scanning: potential for error in interpretation. Semin Nucl Med. 1996; 26:308–314. PMID: 8916319.

13. Drenth JP, Nagengast FM, Oyen WJ. Evaluation of (pre-)malignant colonic abnormalities: endoscopic validation of FDG-PET findings. Eur J Nucl Med. 2001; 28:1766–1769. PMID: 11734913.

14. Roh SH, Jung SA, Kim SE, et al. The clinical meaning of benign colon uptake in ¹⁸F-FDG PET: comparison with colonoscopic findings. Clin Endosc. 2012; 45:145–150.

15. Kim S, Chung JK, Kim BT, et al. Relationship between gastrointestinal F-18-fluorodeoxyglucose accumulation and gastrointestinal symptoms in whole-body PET. Clin Positron Imaging. 1999; 2:273–279. PMID: 14516651.

16. Keogan MT, Lowe VJ, Baker ME, McDermott VG, Lyerly HK, Coleman RE. Local recurrence of rectal cancer: evaluation with F-18 fluorodeoxyglucose PET imaging. Abdom Imaging. 1997; 22:332–337. PMID: 9107663.

17. Strauss LG, Klippel S, Pan L, Schönleben K, Haberkorn U, Dimitrakopoulou-Strauss A. Assessment of quantitative FDG PET data in primary colorectal tumours: which parameters are important with respect to tumour detection? Eur J Nucl Med Mol Imaging. 2007; 34:868–877. PMID: 17219134.

18. Weston BR, Iyer RB, Qiao W, Lee JH, Bresalier RS, Ross WA. Ability of integrated positron emission and computed tomography to detect significant colonic pathology: the experience of a tertiary cancer center. Cancer. 2010; 116:1454–1461. PMID: 20143447.